The newest and most promising drug to fight Alzheimer’s is Leqembi. Carolyn Davis is giving it a try. Learn about the promise, the risks and how it has restored her hope,
Scheduled to begin on May 9, 2024, six new monthly sessions are now available in this free Continuing Education Program.
People with dementia may be even more vulnerable to fraud and scams than previously thought, according to an NIA study. See the story of one victim with a happy ending. Read the research.
Galantamine treats Alzheimer’s. Artificial intelligence and biosensors may pave the way to make this drug faster and cheaper.
A long, long time ago (1930), brains were smaller. Are today’s bigger brains connected to improvements in rates of dementia?
Trontinemab is a very exciting experimental drug, showing great promise in rapidly clearing Alzheimer’s amyloid plaques from the brains of affected individuals, with remarkably little side effects.
See why Cognito’s headset received FDA Breakthrough Device Designation for addressing cognitive and functional symptoms associated with Alzheimer’s.
Fiber improved performance in memory tests associated with early Alzheimer’s in just 12 weeks.
Fiber is cheap, available as over-the counter supplements, safe and just right for these cash-strapped times.
Scientists found a way to predict Alzheimer’s up to seven years before symptoms appear using A.I.
The first 3D-printed brain tissue that can grow and function like typical brain tissue is a major breakthrough for scientists in search of an Alzheimer’s cure.
Swiss researchers find that people with certain personality traits are protected against Alzheimer’s disease, including those who are less agreeable, had natural curiosity, and were nonconformists. Find out why.
If you’ve found a way to make Alzheimer’s care easier or more compassionate, Maude’s Awards want to hear about it.
Dr. Richard Taylor has Alzheimer’s and the right attitude!
In dementia, art is often expressed at a much higher level than other activities. People engaged in artistic activities when they were healthy may hold on to these abilities in a way that seems to defy Alzheimer’s. See the remarkable case of one Canadian sculptor.
One woman held the genetic key to unlock the mystery of how she was the only one free of early-onset Alzheimer’s, out of 1,200 members of a South American family,
Researchers say it takes a dozen “intervention sessions” to improve cognition in those at risk for Alzheimer’s and other dementias.
FDA-approved Sargramostim, a normal human protein, improved memory and cognition in Alzheimer’s patients in a Phase II clinical trial. The drug is safe and well-tolerated, and has been used for other disorders for 30 years.
No spam, only news and updates.
